Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Targeting lactate metabolism for cancer therapeutics
Joanne R. Doherty, John L. Cleveland
Joanne R. Doherty, John L. Cleveland
Published September 3, 2013
Citation Information: J Clin Invest. 2013;123(9):3685-3692. https://doi.org/10.1172/JCI69741.
View: Text | PDF
Review Series Article has an altmetric score of 28

Targeting lactate metabolism for cancer therapeutics

  • Text
  • PDF
Abstract

Lactate, once considered a waste product of glycolysis, has emerged as a critical regulator of cancer development, maintenance, and metastasis. Indeed, tumor lactate levels correlate with increased metastasis, tumor recurrence, and poor outcome. Lactate mediates cancer cell intrinsic effects on metabolism and has additional non–tumor cell autonomous effects that drive tumorigenesis. Tumor cells can metabolize lactate as an energy source and shuttle lactate to neighboring cancer cells, adjacent stroma, and vascular endothelial cells, which induces metabolic reprogramming. Lactate also plays roles in promoting tumor inflammation and in functioning as a signaling molecule that stimulates tumor angiogenesis. Here we review the mechanisms of lactate production and transport and highlight emerging evidence indicating that targeting lactate metabolism is a promising approach for cancer therapeutics.

Authors

Joanne R. Doherty, John L. Cleveland

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2009 Total
Citations: 30 60 54 67 81 54 53 42 36 54 38 12 2 1 584
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article in year 2015 (38)

Title and authors Publication Year
Glycolytic Reprogramming in Myofibroblast Differentiation and Lung Fibrosis
N Xie, Z Tan, S Banerjee, H Cui, J Ge, RM Liu, K Bernard, VJ Thannickal, G Liu
American journal of respiratory and critical care medicine 2015
Epithelial-to-mesenchymal transition induces cell cycle arrest and parenchymal damage in renal fibrosis
S Lovisa, VS LeBleu, B Tampe, H Sugimoto, K Vadnagara, JL Carstens, CC Wu, Y Hagos, BC Burckhardt, T Pentcheva-Hoang, H Nischal, JP Allison, M Zeisberg, R Kalluri
Nature Medicine 2015
Molecular Pathways: Trafficking of Metabolic Resources in the Tumor Microenvironment
IL Romero, A Mukherjee, HA Kenny, LM Litchfield, E Lengyel
Clinical cancer research 2015
Lactate, a putative survival factor for myeloma cells, is incorporated by myeloma cells through monocarboxylate transporters 1
S Fujiwara, N Wada, Y Kawano, Y Okuno, Y Kikukawa, S Endo, N Nishimura, N Ueno, H Mitsuya, H Hata
Experimental Hematology and Oncology 2015
Quantitative constraint-based computational model of tumor-to-stroma coupling via lactate shuttle
F Capuani, DD Martino, E Marinari, AD Martino
Scientific Reports 2015
PTHrP-linked Hypercalcemia in a Melanoma Patient Treated with Ipilimumab: Hormone source and Clinical and Metabolic Correlates
TA Mills, M Orloff, M Domingo-Vidal, P Cotzia, R Birbe, R Draganova-Tacheva, MP Martinez-Cantarin, M Tuluc, U Martinez-Outschoorn
Seminars in Oncology 2015
Warburg-like Glycolysis and Lactate Shuttle in Mouse Decidua during Early Pregnancy
RJ Zuo, XW Gu, QR Qi, TS Wang, XY Zhao, JL Liu, ZM Yang
The Journal of biological chemistry 2015
Novel Therapeutic Targets of Tumor Metabolism:
RJ Kishton, JC Rathmell
The Cancer Journal 2015
Uncovering metabolism in rhabdomyosarcoma
E Monti, A Fanzani
Cell cycle (Georgetown, Tex.) 2015
Lactate dehydrogenase-A inhibition induces human glioblastoma multiforme stem cell differentiation and death
S Daniele, C Giacomelli, E Zappelli, C Granchi, ML Trincavelli, F Minutolo, C Martini
Scientific Reports 2015
Metabolic Signatures of Human Breast Cancer
P Mishra, S Ambs
Molecular & Cellular Oncology 2015
Targeting cancer cell metabolism in pancreatic adenocarcinoma
R Cohen, C Neuzillet, A Tijeras-Raballand, S Faivre, A Gramont, E Raymond
Oncotarget 2015
Contribution of acidic extracellular microenvironment of cancer-colonized bone to bone pain
T Yoneda, M Hiasa, Y Nagata, T Okui, F White
Biochimica et Biophysica Acta (BBA) - Biomembranes 2015
Modulation of Intracellular Calcium Levels by Calcium Lactate Affects Colon Cancer Cell Motility through Calcium-Dependent Calpain
P Sundaramoorthy, JJ Sim, YS Jang, SK Mishra, KY Jeong, P Mander, OB Chul, WS Shim, SH Oh, KY Nam, HM Kim, NA Hotchin
PloS one 2015
Organization of Enzyme Concentration across the Metabolic Network in Cancer Cells
NS Madhukar, MO Warmoes, JW Locasale, VD Appanna
PloS one 2015
Glucose, lactate, and shuttling of metabolites in vertebrate retinas: Lactate Shuttle in the Retina
JB Hurley, KJ Lindsay, J Du
Journal of Neuroscience Research 2015
Melanoma brain metastasis is independent of lactate dehydrogenase A expression
T Sundstrom, H Espedal, PN Harter, KE Fasmer, KO Skaftnesmo, S Horn, E Hodneland, M Mittelbronn, B Weide, R Beschorner, B Bender, CB Rygh, M Lund-Johansen, R Bjerkvig, F Thorsen
Neuro-Oncology 2015
Acidic microenvironment and bone pain in cancer-colonized bone
T Yoneda, M Hiasa, Y Nagata, T Okui, FA White
BoneKEy Reports 2015
Metabolic reprogramming in glioblastoma: The influence of cancer metabolism on epigenetics and unanswered questions
S Agnihotri, G Zadeh
Neuro-Oncology 2015
Does aberrant membrane transport contribute to poor outcome in adult acute myeloid leukemia?
A Chigaev
Frontiers in pharmacology 2015
Progress toward overcoming hypoxia-induced resistance to solid tumor therapy
M Reginato, S Karakashev
Cancer management and research 2015
The predictive value of alkaline phosphatase and lactate dehydrogenase for overall survival in patients with esophageal squamous cell carcinoma
X Wei, D Zhang, M He, Y Jin, D Wang, Y Zhou, L Bai, Z Li, H Luo, F Wang, R Xu
Tumor Biology 2015
Targeted Therapies in Adult B-Cell Malignancies
JF Rossi
BioMed Research International 2015
Severe hyperlactatemia, lactate clearance and mortality in unselected critically ill patients
SA Haas, T Lange, B Saugel, M Petzoldt, V Fuhrmann, M Metschke, S Kluge
Intensive Care Medicine 2015
Long Noncoding RNA Ceruloplasmin Promotes Cancer Growth by Altering Glycolysis
R Rupaimoole, J Lee, M Haemmerle, H Ling, RA Previs, S Pradeep, SY Wu, C Ivan, M Ferracin, JB Dennison, NM Millward, AS Nagaraja, KM Gharpure, M McGuire, N Sam, GN Armaiz-Pena, NC Sadaoui, C Rodriguez-Aguayo, GA Calin, RI Drapkin, J Kovacs, GB Mills, W Zhang, G Lopez-Berestein, PK Bhattacharya, AK Sood
Cell Reports 2015
How, with whom and when: an overview of CD147-mediated regulatory networks influencing matrix metalloproteinase activity
GD Grass, BP Toole
Bioscience Reports 2015
Cryptosporidium Lactate Dehydrogenase Is Associated with the Parasitophorous Vacuole Membrane and Is a Potential Target for Developing Therapeutics
H Zhang, F Guo, G Zhu, LJ Knoll
PLoS pathogens 2015
A Pilot Proteogenomic Study with Data Integration Identifies MCT1 and GLUT1 as Prognostic Markers in Lung Adenocarcinoma
PA Stewart, K Parapatics, EA Welsh, AC Müller, H Cao, B Fang, JM Koomen, SA Eschrich, KL Bennett, EB Haura, JJ Chen
PloS one 2015
MUC16-mediated activation of mTOR and c-Myc reprograms pancreatic cancer metabolism
SK Shukla, V Gunda, J Abrego, D Haridas, A Mishra, J Souchek, NV Chaika, F Yu, AR Sasson, AJ Lazenby, SK Batra, PK Singh
Oncotarget 2015
Metabolic reprogramming and inflammation act in concert to control vascular remodeling in hypoxic pulmonary hypertension
KR Stenmark, RM Tuder, KC el Kasmi
Journal of applied physiology 2015
Clinical development of cancer therapeutics that target metabolism: Figure 1
BF Clem, J ONeal, AC Klarer, S Telang, J Chesney
QJM 2015
Unique metabolic features of pancreatic cancer stroma: relevance to the tumor compartment, prognosis, and invasive potential
ES Knudsen, U Balaji, E Freinkman, P McCue, AK Witkiewicz
Oncotarget 2015
Epigenetic and oncogenic regulation of SLC16A7 (MCT2) results in protein over-expression, impacting on signalling and cellular phenotypes in prostate cancer
Pertega-Gomes N, Vizcaino JR, Felisbino S, Warren AY, Shaw G, Kay J, Whitaker H, Lynch AG, Fryer L, Neal DE, Massie CE
Oncotarget 2015
Targeting metabolic flexibility by simultaneously inhibiting respiratory complex I and lactate generation retards melanoma progression
Chaube B, Malvi P, Singh SV, Mohammad N, Meena AS, Bhat MK
Oncotarget 2015
Active glycolytic metabolism in CD133(+) hepatocellular cancer stem cells: regulation by MIR-122
Song K, Kwon H, Han C, Zhang J, Dash S, Lim K, Wu T
Oncotarget 2015
Silibinin-mediated metabolic reprogramming attenuates pancreatic cancer-induced cachexia and tumor growth
Shukla SK, Dasgupta A, Mehla K, Gunda V, Vernucci E, Souchek J, Goode G, King R, Mishra A, Rai I, Nagarajan S, Chaika NV, Yu F, Singh PK
Oncotarget 2015
Enhanced tumorigenicity by mitochondrial DNA mild mutations.
Cruz-Bermúdez A, Vallejo CG, Vicente-Blanco RJ, Gallardo ME, Fernández-Moreno MÁ, Quintanilla M, Garesse R
Oncotarget 2015
KLF4-SQSTM1/p62-associated prosurvival autophagy contributes to carfilzomib resistance in multiple myeloma models.
Riz I, Hawley TS, Hawley RG
Oncotarget 2015

← Previous 1 2 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Blogged by 3
Posted by 4 X users
Referenced in 12 patents
729 readers on Mendeley
1 readers on CiteULike
See more details